The administration of ciprofloxacin during continuous renal replacement therapy: Pilot study

ASAIO Journal

Volumn 55, Issue 3, 2009, Pages 243-245

  Hayakawa, Mineji ^a   Fujita, Itaru ^b   Iseki, Ken ^b   Gando, Satoshi ^a  

^a HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CIRCUIT MODELS; CRITICALLY-ILL PATIENTS; DIALYSATE; IN-VITRO; OPTIMAL CONCENTRATION; PILOT STUDIES; RENAL REPLACEMENT THERAPIES;

PHARMACOKINETICS; SEMICONDUCTOR QUANTUM DOTS;

ANTIBIOTICS;

CIPROFLOXACIN; CREATININE; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CASE REPORT; CONTINUOUS RENAL REPLACEMENT THERAPY; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DIALYSATE; DRUG CLEARANCE; FLUID FLOW; HUMAN; IN VITRO STUDY; INFECTION; INFECTION CONTROL; MALE; PILOT STUDY; AREA UNDER THE CURVE; CLINICAL TRIAL; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CIPROFLOXACIN; HUMANS; MALE; PILOT PROJECTS; RENAL REPLACEMENT THERAPY;

EID: 67650351042     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e31819962b5     Document Type: Article

References (8)

1. Davis R, Markham A, Balfour JA: Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. Drugs 51: 1019-1074, 1996.
2. Shah A, Lettieri J, Blum R, et al: Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects. J Antimicrob Chemother 38: 103-116, 1996.
3. Bohler J, Donauer J, Keller F: Pharmacokinetic principles during continuous renal replacement therapy: Drugs and dosage. Kidney Int Suppl 72: S24-S28, 1999.
4. Maya MT, Goncalves NJ, Silva NB, et al: Simple high-performance liquid chromatographic assay for the determination of ciprofloxacin in human plasma with ultraviolet detection. J Chromatogr B Biomed Sci Appl 755: 305-309, 2001.
5. Wright DH, Brown GH, Peterson ML, et al: Application of fluoroquinolone pharmacodynamics. J Antimicrob Chemother 46: 669-683, 2000.
6. Yamaoka K, Tanigawara Y, Nakagawa T, et al: A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4: 879-885, 1981.
7. Lipman J, Scribante J, Gous AG, et al: Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis. The Baragwanath Ciprofloxacin Study Group. Antimicrob Agents Chemother 42: 2235-2239, 1998.
8. Brunet S, Leblanc M, Geadah D, et al: Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 34: 486-492, 1999.